Activation of the sigma-1 receptor ameliorates neuronal ferroptosis via IRE1α after spinal cord injury
Brain Research · 2024
DOI: 10.1016/j.brainres.2024.149011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain Research, 2024. Verfasst von Rui Tan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin 300052, PR China. Hauptthemen laut MEDLINE: Spinal Cord Injuries, Receptors, sigma, Ferroptosis, Sigma-1 Receptor. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Tianjin Municipal Science and Technology Bureau.
Abstract (Originalsprache)
Spinal Cord Injury (SCI) is a debilitating disease associated with a significant economic burden owing to its high level of disability; however, current treatment options have only limited efficacy. Past research has shown that iron-dependent programmed cell death, also known as ferroptosis, plays a critical role in the pathogenesis of SCI. The sigma-1 receptor (Sig-1R) is widely distributed in the central nervous system, and has been implicated in the pathophysiology of several neurological and psychiatric disorders. Several in vivo and ex vivo studies have shown that Sig-1R activation exerts unique neuroprotective effects. However, the underlying mechanisms remain unclear. To date, no study has yet demonstrated the association between Sig-1R activation and ferroptosis in patients with SCI. However, the present study found that Sig-1R activation effectively promoted the recovery of motor function in mice after spinal cord injury, attenuated neuronal apoptosis, reduced the production of pro-inflammatory cytokines and iron accumulation, and inhibited ferroptosis in spinal cord tissues following SCI in mice. Ferroptosis and IRE1α were significantly upregulated after spinal cord injury, while sigma-1 receptor agonists were able to facilitate this result through the elimination of inositol-requiring enzyme-1 alpha (IRE1α)-mediated neuronal ferroptosis. Therefore, sigma-1 receptor activation could attenuate ferroptosis after SCI by reducing IRE1α and improving functional recovery after SCI, potentially representing a new therapeutic strategy for treating SCI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin 300052, PR China.
- Department of Molecular Imaging and Nuclear Medicine, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory…
- Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin 300052, PR China. Electronic address: zhutao5@126.com.
Förderung
- Tianjin Municipal Science and Technology Bureau
Zitieren
APA
Tan, R., Sui, C., Diao, Y., Shi, G., Hu, X., Hao, Z., Li, C., Hao, M., Xie, M., & Zhu, T. (2024). Activation of the sigma-1 receptor ameliorates neuronal ferroptosis via IRE1α after spinal cord injury. Brain Research. https://doi.org/10.1016/j.brainres.2024.149011
Vancouver
Tan R, Sui C, Diao Y, Shi G, Hu X, Hao Z, et al. Activation of the sigma-1 receptor ameliorates neuronal ferroptosis via IRE1α after spinal cord injury. Brain Research. 2024. doi:10.1016/j.brainres.2024.149011
BibTeX
@article{Tan2024,
author = {Tan, Rui and Sui, Chunxiao and Diao, Yuhang and Shi, Guihong and Hu, Xiaojun and Hao, Zhenghao and Li, Chenyang and Hao, Mingyu and Xie, Minghao and Zhu, Tao},
title = {Activation of the sigma-1 receptor ameliorates neuronal ferroptosis via IRE1α after spinal cord injury},
journal = {Brain Research},
year = {2024},
doi = {10.1016/j.brainres.2024.149011}
}
EUVIMED